FDA inspection
AstraZeneca UK Ltd.: FDA inspection ending Apr 13, 2017
FDA inspection 1017549 · No Action Indicated (NAI) · Macclesfield
Key facts
| Inspection ID | 1017549 |
|---|---|
| Firm | AstraZeneca UK Ltd. |
| FEI number | 3002850317 |
| Address | Charter Way, Silk Road Business Park |
| City | Macclesfield |
| Country | United Kingdom |
| Fiscal year | 2017 |
| Inspection end date | Apr 13, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data